Moving Forward: Molten completes its acquisition of Forward Partners

Today Molten is delighted to announce that we have completed our acquisition of Forward Partners, a proposition we announced in November last year.

Read More

IMU Biosciences raises £11.5 million Series A

IMU Biosciences secures £11.5 million in Series A funding to revolutionise immune powered precision medicine.

Read More